BUSINESS Glenmark unveils ISB 2301, a groundbreaking multispecific immune activator for solid tumours 4:23 PM IST
BUSINESS Glenmark Pharmaceuticals receives U.S. FDA approval for progesterone vaginal inserts Apr 9, 2026
Glenmark Pharmaceuticals gets U.S. FDA nod for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) Mar 20, 2025
Glenmark Pharmaceuticals shares rise over 2% on U.S. market launch of Vitamin K1 Injectable Emulsion Jan 21, 2025